Radical prostatectomy: pathology compared with other major series findings in 1001 cases and over time

被引:54
作者
Bott, SRJ
Freeman, AA
Stenning, S
Cohen, J
Parkinson, MC
机构
[1] UCL, Inst Urol, London, England
[2] UCL Hosp Trust, London, England
[3] MRC Clin Trials Unit, London, England
关键词
prostate cancer; radical prostatectomy; pathological outcome; surgical margin; stage; biopsy;
D O I
10.1111/j.1464-410X.2005.05245.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To examine the preoperative features and pathological outcomes of clinical significance of 1001 consecutive essentially unscreened men who had a radical prostatectomy [RP) in the UK between 1988 and 2002, and their changes over time. PATIENTS AND METHODS The details of men whose RP specimen was submitted for analysis were entered into the RP database held at the University College Hospital, London; the National Health Service and private patients of 17 surgeons were included. The age, mode of diagnosis, preoperative prostate specific antigen (PSA) level, biopsy and RP findings were compared over time. RESULTS The mean (range) age of the men was 62 (40-76) years, the median PSA 8 (0.1-146) ng/mL and the median biopsy Gleason sum score 6; these preoperative features did not change over the study period. The diagnosis of prostate cancer was made by transurethral resection of the prostate alone in 48 men (5%). The maximum number of patients receiving neoadjuvant androgen ablation was 21 (33%) in 1996, and subsequently declined. The median (range) RP Gleason sum score was 7 (4-9). The biopsy Gleason score correlated with the prostatectomy Gleason score in 252 (47%) of 536 men, being lower in 170 (32%) and higher in 113 (21%). The median tumour volume was 2 mL (focus of invasive acini - 31 mL) and the incidence of positive intra- and extraprostatic margins was 52%. Both tumour volume and extraprostatic margin positivity declined with time. CONCLUSIONS The preoperative features and pathological findings from this UK series are similar to those of other reported cohorts from unscreened populations. The incidence of positive extraprostatic surgical margins, tumour volume and stage decreased with time.
引用
收藏
页码:34 / 39
页数:6
相关论文
共 50 条
  • [1] Insignificant prostate cancer in radical prostatectomy specimen: Time trends and preoperative prediction
    Augustin, H
    Hammerer, PG
    Graefen, M
    Erbersdobler, A
    Blonski, J
    Palisaar, J
    Daghofer, F
    Huland, H
    [J]. EUROPEAN UROLOGY, 2003, 43 (05) : 455 - 460
  • [2] Babaian RJ, 2001, CANCER, V91, P1414
  • [3] Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
    Barocas, DA
    Han, M
    Epstein, JI
    Chan, DY
    Trock, BJ
    Walsh, PC
    Partin, AW
    [J]. UROLOGY, 2001, 58 (05) : 746 - 751
  • [4] Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy
    Blute, ML
    Bostwick, DG
    Bergstralh, EJ
    Slezak, JM
    Martin, SK
    Amling, CL
    Zincke, H
    [J]. UROLOGY, 1997, 50 (05) : 733 - 739
  • [5] Avoidance and management of positive surgical margins before, during and after radical prostatectomy
    Bott, SRJ
    Kirby, RS
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2002, 5 (04) : 252 - 263
  • [6] Accuracy of biopsy Gleason scores from a large uropathology laboratory: Use of a diagnostic protocol to minimize observer variability
    Carlson, GD
    Calvanese, CB
    Kahane, H
    Epstein, JI
    [J]. UROLOGY, 1998, 51 (04) : 525 - 529
  • [7] 5-YEAR TUMOR RECURRENCE RATES AFTER ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE-CANCER
    CATALONA, WJ
    SMITH, DS
    [J]. JOURNAL OF UROLOGY, 1994, 152 (05) : 1837 - 1842
  • [8] Cheng L, 1999, CANCER, V86, P1775, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1775::AID-CNCR20>3.0.CO
  • [9] 2-L
  • [10] A MULTIVARIATE-ANALYSIS OF CLINICAL AND PATHOLOGICAL FACTORS THAT PREDICT FOR PROSTATE-SPECIFIC ANTIGEN FAILURE AFTER RADICAL PROSTATECTOMY FOR PROSTATE-CANCER
    DAMICO, AV
    WHITTINGTON, R
    MALKOWICZ, SB
    SCHULTZ, D
    SCHNALL, M
    TOMASZEWSKI, JE
    WEIN, A
    [J]. JOURNAL OF UROLOGY, 1995, 154 (01) : 131 - 138